- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01805973
Surviving Aneurysm Surgery: A Pilot Study on Exercise Training in Abdominal Aortic Aneurysm Patients (SAS)
Surviving Aneurysm Surgery: A Pilot Randomised Controlled Trial on Exercise Training in Abdominal Aortic Aneurysm Patients
An abdominal aortic aneurysm (AAA) is an enlargement or ballooning of the main artery supplying high pressure blood from the heart to the body. AAAs may continue to stretch until they burst (rupture) causing 7000 deaths per year in the United Kingdom (UK); 2.1% of all deaths in men over 65. Planned repair before rupture is critical and the National AAA Screening Programme (NAAASP) is being introduced to identify AAAs in men before rupture. Screening will identify over 9000 men per year with a previously undiagnosed AAA. More than 90% of screen detected AAAs are small, do no require repair, enter ultrasound follow-up (surveillance) and may benefit from exercise to improve fitness before repair.
Over 4000 elective AAA repairs per year are performed in the UK and it has been suggested that exercise training and weight loss may reduce mortality and complications of AAA repair. This pilot study will examine the feasibility of supervised exercise training for patients with AAAs and determine the optimal duration of training to achieve worthwhile improvements in fitness.
Study Overview
Status
Intervention / Treatment
Detailed Description
Abdominal aortic aneurysm (AAA) affects 4% of men aged 65-79, a prevalence rising as our population ages. As most patients suffering rupture die immediately, elective AAA repair is critical and the National AAA Screening Programme (NAAASP) is being implemented across the UK to identify AAAs for elective repair. Manchester is the first major urban population to be screened. The UK had the highest mortality rates following elective open AAA repair in Europe (7% v 3.5%); the AAA Quality Improvement Programme's (AAAQIP) target is to reduce this to under 3.5% by 2013.
The benefits of exercise across a broad spectrum of medical conditions are now increasingly recognised; especially in the elderly. Exercise training may reduce mortality and complications in major surgery. Cardiopulmonary exercise testing (CPET) measures cardiopulmonary reserve and predicts outcome in major surgery. The Manchester CPET study group demonstrated that anaerobic threshold (AT) and peak oxygen consumption (VO2 peak) predict 30 and 90-day mortality in elective AAA repair.
The investigators propose a pilot randomised controlled trial (RCT) to determine whether a structured exercise programme improves fitness measured by CPET, and the optimal duration of training for AAA surgery. As over 90% of AAAs detected by screening are < 5.5cm and enter surveillance, these patients offer a unique opportunity to explore the ideal duration of exercise training as surgery is not indicated for months or years.
100 participants on AAA surveillance will be recruited and randomised to either exercise training or standard preoperative care (50 in each arm) to answer the following research questions:
- Can a supervised exercise programme improve performance in CPET measures that predict outcome in AAA surgery?
- What is the optimal period of training needed to achieve a significant improvement in CPET scores?
- How long is any exercise-induced improvement in fitness sustained?
- The economic and health costs of a supervised exercise training programme
Exercise subjects will attend a 60 minute supervised exercise programme of moderate intensity (70% of heart rate reserve) x3/week at a local gym. All participants will undergo CPET assessment of cardiopulmonary fitness and complete a health-related quality of life (Medical Outcomes Study 36-Item Short-Form Health Survey) at baseline and 18 weeks. The exercise subjects will undergo further CPET studies at 6, 12 and 36 weeks to investigate the duration of training needed to optimise fitness and the length of time improvements in fitness persist. Other important health related outcomes include blood pressure and lipid profile and frequency of health service visits (e.g. General Practitioner appointments) will be recorded for all participants at baseline and 18 weeks to provide data on the effects of exercise on health care costs. Longitudinal regression models, with Normal and Poisson distributions as appropriate, will be used to assess differences between the groups with respect to CPET changes, other health-related outcomes and frequency of health service visits over the whole study period. This pilot study will also explore strategies to encourage participation and compliance with exercise which may also improve general health outcomes and save National Health Service (NHS) costs by reducing demand.
The overall aim is to collect the data needed to design a definitive multicentre trial on whether physical exercise reduces morbidity and/or mortality in AAA repair.
Those aged >65 are the fastest growing segment of our population. This pilot study will contribute to public health policy drive on the impact of physical activity on functional capacity, quality of life and independence.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Lancashire
-
Manchester, Lancashire, United Kingdom, M23 9LT
- University Hospital of South Manchester NHS Foundation Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men or women with an AAA ≥3.5cm to <5.5cm in men and ≥3.5cm to <5.0cm in women
- Age 50-85 years and willing to consider exercise training
- Fit for either open or Endovascular Aneurysm Repair AAA repair
Exclusion Criteria:
- Unable to participate in an exercise test or inability to exercise consistently because of musculoskeletal or other health problems
- History of severe liver disease (INR>2, serum albumin <3.0g/dL, jaundice)
- Unstable angina: Patients with angina of less than 2 months' duration, severe or occurring three or more times per day, or angina that is becoming either more frequent of precipitated by less exertion or angina at rest
- Uncontrolled atrial fibrillation (AF) or other arrhythmia: Untreated episodes of paroxysmal AF in the last 3 months
- Moderate or severe aortic valve stenosis (peak systolic pressure gradient > 40mmHg and with an aortic valve area of <1cm^2.
- Class III/IV heart failure and / or an ejection fraction <25%
- Active pericarditis or myocarditis
- CPET induced ischaemia
- Diagnosis or treatment for a malignancy (excluding skin) over the previous 12 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Standard pre-operative care, no active intervention
|
|
Experimental: Exercise Training
Supervised Exercise Training Programme Patients will be required to attend three 50 minute exercise sessions per week for 18 weeks. They will exercise in groups of 8-12 and will be supervised by an experienced exercise physiologist. Each session will comprise a 15 minute warm up, 30 minutes of moderate intensity aerobic exercise followed by a 10 minute cool down period. The patients will have the option to choose from three different exercise programmes tailored to individuals of mixed abilities (and co-morbidities). |
Patients will participate in a supervised exercise training programme for 18 weeks.
Patients will participate in a 50 minute exercise regime three times a week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiopulmonary Exercise Test Score
Time Frame: 18 weeks
|
The investigators will determine if supervised exercise training improves cardiopulmonary fitness.
Peak oxygen uptake and ventilatory threshold will be assessed during an incremental-load cycling test.
|
18 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiopulmonary Exercise Test Score
Time Frame: 12 weeks
|
For the intervention (exercise) arm the investigators will assess the CPET score at 6 and 12 weeks to determine the optimal duration of exercise training. Peak oxygen uptake and ventilatory threshold will be assessed during an incremental-load cycling test. |
12 weeks
|
Cardiopulmonary Exercise Test Score
Time Frame: 36 weeks
|
The investigators will determine how long any improvements in fitness are sustained after exercise is stopped. Peak oxygen uptake and ventilatory threshold will be assessed during an incremental-load cycling test. |
36 weeks
|
Health-related quality of life
Time Frame: 18 weeks
|
Fasting blood samples will be taken to assess changes in lipid profile and other biomarkers of cardiovascular disease. Blood pressure control will be monitored. |
18 weeks
|
Quality of Life
Time Frame: 18 weeks
|
Health-related quality of life will be assessed using the Medical Outcomes Study Short Form-36 questionnaire.
|
18 weeks
|
Cost
Time Frame: 18 weeks
|
A preliminary economic analysis will be performed to determine the cost of prescribed exercise training before surgery.
|
18 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Charles M McCollum, MD, Manchester University NHS Foundation Trust
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013VSAS001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruitingCardiovascular DiseaseUnited States
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Penn State UniversityCalifornia Healthcare InstituteCompleted
-
Penn State UniversityAlmond Board of California; The Hershey CompanyCompletedCardiovascular DiseaseUnited States
-
VA Office of Research and DevelopmentCompleted
-
Aziyo Biologics, Inc.CompletedCardiovascular DiseaseUnited States
-
Monash UniversityCompletedCardiovascular DiseaseAustralia
Clinical Trials on Exercise Training
-
University of British ColumbiaMichael Smith Foundation for Health ResearchCompleted
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Universidade Norte do ParanáCompleted
-
University of Colorado, DenverVA Eastern Colorado Health Care SystemCompletedHealthy | Overweight | Type 2 Diabetes Mellitus | Cardiovascular Risk FactorUnited States
-
National Taiwan University HospitalCompletedAtrial FibrillationTaiwan
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
University of LeipzigCompletedImpact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable CADStable Coronary Artery DiseaseGermany
-
Helse Stavanger HFStavanger Health ResearchCompletedVentricular TachycardiaNorway
-
Universita di VeronaRecruiting
-
Hacettepe UniversityCompleted